Meet the ApiJect Business Development Team
Our Approach
At ApiJect, our Business Development team partners with you to provide a turnkey combination product development through commercial manufacturing solution using our single-use blow-fill-seal injection platform. We work with you to identify the appropriate injector device design, ensure feasibility and identify a manufacturing solution that best fits your injectable or vaccine needs.
|
Bo Kowalczyk, Chief Commercial Officer |
|
 Prior to joining ApiJect, Bo served as the Vice President of Sales, North America, for Syngene International’s Chemical Development and Manufacturing division, where he aligned operational expertise with prospecting efforts to target the right opportunities and maximize client satisfaction. Bo served as Global VP, Business Development and Marketing with Eurofins Biologics Bioanalytical Services where he led efforts to integrate Bioanalytical Services with Eurofins Central Lab Services to provide seamless services for clinical trial logistics and sample testing support. He served as Vice President, Business Development and Marketing at AIT Bioscience where he successfully grew sales & profitability over a 5- year period in part by creating a network of third-party preclinical toxicology service providers allowing AIT Bioscience earlier access to promising therapeutic candidates moving into clinical trials. |
|
|
PJ Kim, Vice President, Business Development |
|
|
PJ Kim’s 19+ years in regulated pharmaceuticals, healthcare, and clinical trials includes responsibilities in quality, sales, program management, key account management, and corporate strategy. At ApiJect, Mr. Kim is responsible for developing strategic plans for new and existing key accounts in drug delivery design, development, and manufacturing utilizing ApiJect’s technology. Previously, Mr. Kim served as an Executive Director in Syngene International’s NA CDMO business, developing new integrated drug development programs. Earlier posts included Pharmaceutics International’s Head of Commercial and Corporate Development, and Account Manager with Johnson Matthey, identifying API portfolio business opportunities and negotiating contracts. At Advanced Bioscience Laboratories, he was directly responsible for new growth, capturing and developing key large pharma and R&D programs. As Head of Quality and Regulatory at Cleveland Clinic’s Taussig Cancer Institute, he managed a team of monitors and auditors ensuring compliance the NCI regulations on IND studies. His career began at Ben Venue Laboratories starting as a bench chemist, moving to quality assurance, and eventually landing in account management focusing on servicing BVL’s sterile injectable clients. Mr. Kim earned his MBA from Baldwin-Wallace College and a Bachelor’s in Biology with a Chemistry minor at Case Western Reserve. |
|
